lomustine
Showing 1 - 25 of 73
First Progression of Glioblastoma Trial (Lomustine, Reirradiation)
Not yet recruiting
- First Progression of Glioblastoma
- Lomustine
- Reirradiation
- (no location specified)
Jun 6, 2023
First Progression of MGMT Promoter-methylated Glioblastoma Trial in Bellinzona, Zürich (Lomustine, Romiplostim)
Recruiting
- First Progression of MGMT Promoter-methylated Glioblastoma
- Lomustine
- Romiplostim
-
Barcelona, Spain
- +4 more
Nov 16, 2022
Glioblastoma Trial in San Antonio (Lomustine, Imipramine Hydrochloride)
Recruiting
- Glioblastoma
- Lomustine
- Imipramine Hydrochloride
-
San Antonio, TexasMays Cancer Center, UT Health San Antonio
Jul 21, 2022
Glioblastoma Trial (Onfekafusp alfa, Lomustine)
Not yet recruiting
- Glioblastoma
- Onfekafusp alfa
- Lomustine
- (no location specified)
Apr 19, 2022
Glioblastoma Trial in Zürich (L19TNF, Lomustine)
Recruiting
- Glioblastoma
- L19TNF
- Lomustine
-
Zürich, SwitzerlandUniversitatspital Zurich - Klinik fur Neurologie & Hirntumorzent
Apr 19, 2022
IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal
Terminated
- IDH Family Wildtype
- +2 more
- Laser Interstitial Thermal Therapy
- Lomustine
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)
Not yet recruiting
- Glioblastoma
- +2 more
- SonoCloud-9 (SC9)
- +3 more
-
Chicago, Illinois
- +7 more
Jun 5, 2023
Glioblastoma, Recurrent Glioblastoma Trial in Iowa City (Static Magnetic and Electric (sBE) device, Lomustine, Bevacizumab)
Not yet recruiting
- Glioblastoma
- Recurrent Glioblastoma
- Static Magnetic and Electric (sBE) device
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Sep 20, 2022
Solid Tumors (Phase 1), Relapsed/Recurrent GBM (Phase 2) Trial in Spain, United States (USL311, Lomustine)
Terminated
- Solid Tumors (Phase 1)
- Relapsed/Recurrent GBM (Phase 2)
- USL311
- Lomustine
-
Saint Louis, Missouri
- +5 more
Jul 1, 2021
Glioblastoma Multiforme, Cognition Disorders, Disability Evaluation Trial in Den Haag, Rotterdam (biological, drug, genetic,
Completed
- Glioblastoma Multiforme
- +2 more
- bevacizumab
- +5 more
-
Den Haag, Netherlands
- +1 more
Feb 11, 2021
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Trial in Fullerton, Newport Beach, Santa Monica (ABI-009,
Active, not recruiting
- High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
- ABI-009
- +5 more
-
Fullerton, California
- +2 more
Jun 13, 2022
Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)
Active, not recruiting
- Anaplastic Astrocytoma
- Recurrent Anaplastic Astrocytoma
- Eflornithine
- Lomustine
-
Birmingham, Alabama
- +78 more
Jan 19, 2022
Glioblastoma, Diffuse Glioma Trial in Worldwide (NMS-03305293 + TMZ, Lomustine)
Recruiting
- Glioblastoma
- Diffuse Glioma
- NMS-03305293 + TMZ
- Lomustine
-
Rochester, Minnesota
- +3 more
Mar 11, 2022
Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)
Active, not recruiting
- Glioblastoma Multiforme
- VBI-1901
- +2 more
-
Los Angeles, California
- +3 more
Jun 27, 2022
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell
Completed
- AIDS-related Diffuse Large Cell Lymphoma
- +8 more
- cyclophosphamide
- +7 more
-
Eldoret, Kenya
- +1 more
Sep 12, 2022
Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Atlanta (Liothyronine, Lomustine, Methimazole)
Recruiting
- Recurrent Glioblastoma
- Recurrent Gliosarcoma
- Liothyronine
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Feb 23, 2022
Glioblastoma Multiforme Trial in Italy (Regorafenib, Lomustine)
Active, not recruiting
- Glioblastoma Multiforme
- Regorafenib
- Lomustine
-
Castellana Grotte, BA, Italy
- +9 more
Mar 31, 2022
Recurrent Glioblastoma Multiforme Trial in Worldwide (buparlisib, carboplatin, lomustine)
Completed
- Recurrent Glioblastoma Multiforme
- buparlisib
- +3 more
-
Phoenix, Arizona
- +13 more
Dec 6, 2020
Glioblastoma Multiforme, Glioblastoma, Adult, Glioblastoma Trial in Amsterdam, Groningen, Nijmegen (Sunitinib, Lomustine)
Recruiting
- Glioblastoma Multiforme
- +4 more
- Sunitinib
- Lomustine
-
Amsterdam, Netherlands
- +2 more
Apr 14, 2021
Glioblastoma Multiforme, Adult Trial in Worldwide (Berubicin, Lomustine)
Recruiting
- Glioblastoma Multiforme, Adult
- Berubicin
- Lomustine
-
Phoenix, Arizona
- +49 more
Aug 17, 2022
Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)
Active, not recruiting
- Glioblastoma
- LY2157299 monohydrate
- +2 more
-
Birmingham, Alabama
- +26 more
Oct 18, 2022
Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)
Recruiting
- Glioblastoma
- Gliosarcoma
- Lomustine
- +4 more
-
Little Rock, Arkansas
- +119 more
Aug 11, 2022